Tarsometatarsal Arthrodesis Treatment Market Size, Share and Trends Analysis 2026 to 2035

Tarsometatarsal Arthrodesis Treatment Market Size is valued at USD 1.07 Bn in 2025 and is predicted to reach USD 2.05 Bn by the year 2035 at a 6.8% CAGR during the forecast period for 2026 to 2035.

Tarsometatarsal Arthrodesis Treatment Market Size, Share & Trends Analysis Distribution by Type (Plating Systems, K-wires, and Crossing Screws), Material (Stainless Steel and Titanium), End-user (Hospitals, Orthopedic Outpatient Clinics, and Ambulatory Surgical Centers), and Segment Forecasts, 2026 to 2035

In recent decades, the shift toward precision and minimally invasive techniques has quietly become one of the most important advances in modern foot and ankle surgery. Tarsometatarsal arthrodesis (TMT fusion) exemplifies this evolution: by permanently stabilizing the midfoot joints between the tarsal and metatarsal bones, the procedure eliminates painful motion while restoring alignment and load-bearing capacity. It is now a standard intervention for severe midfoot arthritis, post-traumatic instability, progressive deformities, and chronic joint pain refractory to non-operative care. Surgeons remove damaged cartilage, realign the bony surfaces, and achieve rigid fixation with screws, plates, or staples, typically resulting in reliable pain relief and improved function at the cost of some midfoot flexibility. The procedure’s growing role reflects an aging population with more degenerative joint disease, increasing sports-related midfoot trauma, and greater recognition of the TMT complex as a frequent source of disabling foot pain.

One of the main drivers of the tarsometatarsal arthrodesis treatment market's expansion is the rising need for minimally invasive procedures. This can be attributed to the less invasive nature of tarsometatarsal arthrodesis treatment. Additionally, the industry is also experiencing significant expansion due to the increased knowledge of the advantages of tarsometatarsal arthrodesis treatment. This is because the treatment of foot and ankle injuries with Tarsometatarsal Arthrodesis is quite successful. The demand for efficient treatments is anticipated to grow as the population ages and lifestyle-related illnesses become more common, resulting in a healthy business climate. Moreover, there are opportunities for expansion due to continuous research and development initiatives targeted at improving surgical methods and post-operative care.

Moreover, better fusion rates and fewer problems are anticipated as a result of this individualized method becoming commonplace. A significant trend that aims to reduce patient morbidity and do away with the requirement for hardware removal surgery is the development of bioabsorbable fixation devices. Furthermore, the advanced surgical techniques are also becoming more accessible due to significant investments made by both public and private organizations in enhancing healthcare infrastructure and accessibility. Thus, this is anticipated to boost the tarsometatarsal arthrodesis treatment market growth over the forecast period.

Competitive Landscape

Which are the Leading Players in Tarsometatarsal Arthrodesis Treatment Market?

• DePuySynthes
• Medline Industries Inc.
• Acumed LLC
• Stryker GmbH
• Biomet Trauma
• Nextremity Solutions Inc.
• Wright Medical Technology Inc.
• Integra Lifesciences Corporation
• Novastep Inc.
• Paragon 28 Inc.
• Orthofix Medical Inc.
• Others

Market Dynamics

Driver

Growing Prevalence of Traumatic Injuries

The growing prevalence of traumatic injuries and midfoot disorders, especially Lisfranc injury and degenerative osteoarthritis, is one of the main factors propelling the tarsometatarsal arthrodesis treatment market. The number of patients needing surgery for persistent midfoot pain and instability has increased due in large part to age-related joint degradation, increased involvement in sports, and traffic accidents. Furthermore, the demand for corrective and pain-relieving surgical operations has been further spurred by the global increase in the senior population, who are more susceptible to structural foot abnormalities and arthritis. Improved surgical methods, better fixation devices, and better postoperative results have also boosted patient acceptability and physician confidence, which has supported the tarsometatarsal arthrodesis treatment market growth.

Restrain/Challenge

High Procedure Cost and Related Postoperative Recovery

The high procedure cost and related postoperative recovery burden are a significant barrier to the tarsometatarsal arthrodesis treatment market. The procedure calls for specialist implants like plates and screws, sophisticated imaging guidance, and knowledgeable orthopedic surgeons, all of which raise the total cost of care. Limited reimbursement coverage and high out-of-pocket expenses limit patient access to the surgery in many developing and cost-sensitive nations. Additionally, when conservative treatment alternatives are still available, the risk of complications such as infection, nonunion, hardware irritation, and protracted immobilization can deter patients and healthcare professionals from choosing surgical fusion.

Plating Systems Segment is Expected to Drive the Tarsometatarsal Arthrodesis Treatment Market

The plating systems category held the largest share in the tarsometatarsal arthrodesis treatment market in 2025 as a result of surgeons' growing predilection for strict internal fixation techniques that offer better stability and fusion results. Plate systems provide more biomechanical support than individual screws, especially in cases of revision surgery, multi-joint fusions, and complex midfoot abnormalities. Orthopedic surgeons have turned to them because of their ability to preserve exact anatomical alignment while lowering the possibility of hardware failure or nonunion. Additional technological developments that have increased procedural success rates and decreased postoperative problems include locking plate designs, low-profile anatomical plates, and better biocompatible materials.

Hospitals Segment is Growing at the Highest Rate in the Tarsometatarsal Arthrodesis Treatment Market

In 2025, the hospitals category dominated the tarsometatarsal arthrodesis treatment market as a result of the growing demand for sophisticated surgical environments with specialist orthopedic infrastructure. Hospitals are usually the main locations for complicated foot and ankle surgeries because they provide access to skilled orthopedic surgeons, cutting-edge imaging equipment, and extensive postoperative care settings. In addition to improving surgical results and patient safety, the availability of multidisciplinary teams that include anesthesiologists and rehabilitation specialists encourages more patients to seek treatment in hospitals. Furthermore, the increasing incidence of hospitalizations for age-related degenerative diseases, sports-related midfoot fractures, and traumatic injuries supports procedural volumes.

Why North America Led the Tarsometatarsal Arthrodesis Treatment Market?

The tarsometatarsal arthrodesis treatment market was dominated by North America region in 2025 driven by a high rate of foot abnormalities, arthritis, and sophisticated medical facilities. Due to their well-established orthopedic care systems, extensive network of specialist surgical centers, and robust reimbursement structures that promote the use of arthrodesis treatments, the United States and Canada lead the world in procedure volumes. The advanced fixation systems are becoming more and more popular among clinicians due to technological advancements such as bioabsorbable materials, optimized implant designs, and minimally invasive surgical methods that improve patient outcomes. Furthermore, the need for corrective arthrodesis surgery is growing as individuals and medical professionals become more aware of foot and ankle conditions. North America's supremacy is further cemented by high healthcare costs and continuous R&D investments by significant medical device makers.

Tarsometatarsal Arthrodesis Treatment Market Report Scope: